Related references
Note: Only part of the references are listed.Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty et al.
ANNALS OF SURGERY (2021)
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma
Biqi Zhang et al.
ANNALS OF SURGERY (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy
Shimpei Maeda et al.
SURGERY (2020)
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh et al.
ANNALS OF SURGERY (2019)
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma A Propensity Score Adjusted Analysis
Jordan M. Cloyd et al.
PANCREAS (2019)
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Laura Maggino et al.
JAMA SURGERY (2019)
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
Jin He et al.
ANNALS OF SURGERY (2018)
Locally advanced pancreas cancer: Staging and goals of therapy
Nikolaos A. Chatzizacharias et al.
SURGERY (2018)
Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma
Susanna W. L. de Geus et al.
HPB (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer
Ihsan Ekin Demir et al.
ANNALS OF SURGERY (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits
Stefan Heinrich et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery
Marc G. Besselink et al.
SURGERY (2017)
Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
Kyung Su Kim et al.
CANCER RESEARCH AND TREATMENT (2017)
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy
Deyali Chatterjee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis
Stephan Schorn et al.
CANCER TREATMENT REVIEWS (2017)
Pancreatic Cancer Surgery The New R-status Counts
Oliver Strobel et al.
ANNALS OF SURGERY (2017)
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
Li Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
Juan W. Valle et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
Jeannelyn S. Estrella et al.
CANCER (2012)
R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use
Bettina M. Rau et al.
SURGERY (2012)
A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
Jerome Martin Laurence et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Pancreatoduodenectomy for Ductal Adenocarcinoma Implications of Positive Margin on Survival
Javairiah Fatima et al.
ARCHIVES OF SURGERY (2010)
Redefining resection margin status in pancreatic cancer
Caroline S. Verbeke et al.
HPB (2009)
Influence of resection margins and treatment on survival in patients with pancreatic cancer - Meta-analysis of randomized controlled trials
Giovanni Butturini et al.
ARCHIVES OF SURGERY (2008)
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Arne Westgaard et al.
BMC CANCER (2008)
Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer
Karl Y. Bilimoria et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Delayed gastric emptying (DGE) after pancreatic surgery:: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Moritz N. Wente et al.
SURGERY (2007)
Trends in the treatment and outcome of pancreatic cancer in the United States
Nancy N. Baxter et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
Jordan M. Winter et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Share Paper
